- Home
- MDGL vs KTOS Comparison
MDGL vs KTOS Comparison
Compare MDGL & KTOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- KTOS
- Stock Information
- Founded
- MDGL 2011
- KTOS 1994
- Country
- MDGL United States
- KTOS United States
- Employees
- MDGL N/A
- KTOS N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- KTOS Military/Government/Technical
- Sector
- MDGL Health Care
- KTOS Industrials
- Exchange
- MDGL Nasdaq
- KTOS Nasdaq
- Market Cap
- MDGL 6.1B
- KTOS 6.2B
- IPO Year
- MDGL N/A
- KTOS 1999
- Fundamental
- Price
- MDGL $304.86
- KTOS $46.04
- Analyst Decision
- MDGL Strong Buy
- KTOS Buy
- Analyst Count
- MDGL 9
- KTOS 10
- Target Price
- MDGL $420.63
- KTOS $41.80
- AVG Volume (30 Days)
- MDGL 305.4K
- KTOS 4.4M
- Earning Date
- MDGL 08-06-2025
- KTOS 08-06-2025
- Dividend Yield
- MDGL N/A
- KTOS N/A
- EPS Growth
- MDGL N/A
- KTOS N/A
- EPS
- MDGL N/A
- KTOS 0.13
- Revenue
- MDGL $317,383,000.00
- KTOS $1,161,700,000.00
- Revenue This Year
- MDGL $286.17
- KTOS $15.46
- Revenue Next Year
- MDGL $64.17
- KTOS $15.70
- P/E Ratio
- MDGL N/A
- KTOS $364.17
- Revenue Growth
- MDGL N/A
- KTOS 7.32
- 52 Week Low
- MDGL $200.63
- KTOS $17.91
- 52 Week High
- MDGL $377.46
- KTOS $47.09
- Technical
- Relative Strength Index (RSI)
- MDGL 61.70
- KTOS 56.06
- Support Level
- MDGL $277.64
- KTOS $40.10
- Resistance Level
- MDGL $314.22
- KTOS $46.52
- Average True Range (ATR)
- MDGL 11.62
- KTOS 2.22
- MACD
- MDGL 3.11
- KTOS -0.15
- Stochastic Oscillator
- MDGL 82.64
- KTOS 39.79
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About KTOS Kratos Defense & Security Solutions Inc.
Kratos Defense & Security Solutions Inc develops and fields transformative, affordable technology, platforms, and systems. The company has two segments; The Kratos Government Solutions (KGS) segment is comprised of an aggregation of KGS operating segments, including its microwave electronic products, space, training, and cybersecurity, C5ISR/modular systems, turbine technologies, and defense and rocket support services operating segments and The Unmanned Systems segment consists of unmanned aerial, unmanned ground, unmanned seaborne and related command, control, and communications system businesses. The company derives a majority of its revenue from the Kratos Government Solutions segment.